Research
A protein in the brain's immune cells may accelerate damage in Alzheimer's disease
The Brief
- Researchers at Lund University in Sweden identified a role for the protein galectin-3 in Alzheimer's disease.
- The study indicates galectin-3 affects how brain microglia react to amyloid plaques.
- The source excerpt is truncated, so further findings cannot be confirmed from the provided material.
Why it matters
The findings point to a specific immune-cell protein that may influence how Alzheimer's damage progresses, which could inform future research into therapeutic targets.
Who’s affected
- Alzheimer's researchers
- neuroscientists studying microglia and neuroinflammation
Researchers at Lund University in Sweden have identified a key role for the protein galectin-3 in Alzheimer's disease. The study shows that galectin-3 not only influences how the brain's immune cells, known as microglia, react to the disease's characteristic amyloid plaques but…